Cookies help us deliver our services. By using our services, you agree to our use of cookies. Learn more

Aagenaes Syndrome

What is Aagenaes Syndrome?

Aagenaes syndrome, also known as lymphedema-cholestasis syndrome (LCS), is a rare genetic disease affecting the liver and is characterized by a reduced size and number of the lymph vessels. Lymph vessels carry a protein-rich fluid called lymphatic fluid. People with Aagenaes syndrome suffer from lymphedema, in which lymph fluid builds up in tissues of the body, causing the affected area to swell.

The malfunction of the lymph nodes can also cause cholestasis, the obstruction of the flow of the bile. Bile is a fluid produced in the liver that aids in digestion. Bile helps to incorporate the fat that we eat and the vitamins dissolved in this fat into our digestive tract for use in the body. If the bile flow is reduced, this decreases the body’s access to critical vitamins. This symptom of Aagenaes syndrome can be treated with vitamins and nutrition supplements.

The disorder can sometimes cause scarring of the liver (cirrhosis) later in childhood or during life. Cirrhosis develops in about 25% of people with Aagenaes syndrome.

This condition has been reported more often in Norway, and was first described by Aagenaes et al. in Norway in 1968 (1). It is caused by mutations in the LSC1 gene, on chromosome 15q.

 

 

Synonyms

  • Cholestasis-edema syndrome, Norwegian type
  • Cholestasis-lymphedema syndrome
  • Cholestatic jaundice with hereditary lymphedema
  • Norwegian cholestasis

Aagenaes syndrome, also known as lymphedema-cholestasis syndrome (LCS), is a rare genetic disease affecting the liver and is characterized by a reduced size and number of the lymph vessels. Lymph vessels carry a protein-rich fluid called lymphatic fluid. People with Aagenaes syndrome suffer from lymphedema, in which lymph fluid builds up in tissues of the body, causing the affected area to swell.

The malfunction of the lymph nodes can also cause cholestasis, the obstruction of the flow of the bile. Bile is a fluid produced in the liver that aids in digestion. Bile helps to incorporate the fat that we eat and the vitamins dissolved in this fat into our digestive tract for use in the body. If the bile flow is reduced, this decreases the body’s access to critical vitamins. This symptom of Aagenaes syndrome can be treated with vitamins and nutrition supplements.

The disorder can sometimes cause scarring of the liver (cirrhosis) later in childhood or during life. Cirrhosis develops in about 25% of people with Aagenaes syndrome.

This condition has been reported more often in Norway, and was first described by Aagenaes et al. in Norway in 1968 (1). It is caused by mutations in the LSC1 gene, on chromosome 15q.

 

Acknowledgement of Aagenaes Syndrome has not been added yet.

Aagenaes syndrome is a rare disease with less than 1,000 cases in the U.S. This disease was first described by Aagenaes (a pediatrician) in Norway in 1968. The Norwegian individuals diagnosed with Aagenaes syndrome most likely have a similar gene mutation that was genetically inherited from a common ancestor. Thus, people in Norway are more likely to carry the genetic mutation that causes Aagenaes syndrome, and there is a higher rate of this rare disease in Norway than anywhere else in the world. 

 

Name Abbreviation
Cholestasis-edema syndrome, Norwegian type CES
Cholestasis-lymphedema syndrome CLS
Cholestatic jaundice with hereditary lymphedema CJHL
Norwegian cholestasis NC

Aageneas syndrome is a genetic disorder caused by a mutation in a person’s genes producing an abnormal effect on their body. Some cases of Aagenaes syndrome have been linked to an auto-recessive mutation in the LSC1 gene on human chromosome 15q. Auto-recessive disorders refer to genetic mutations that are present in both parent’s chromosomes, resulting in an offspring with a pair of chromosomes with the same mutation, in this case chromosome 15q. While this gene and locus have been associated with individuals diagnosed with Aagenaes syndrome, the current cause of cholestasis from Aagenaes syndrome is unknown. Current research hypothesizes that the mutation associated with this rare disease affects the lymphatic system and that the liver itself is healthy. The lymphatic system refers to a system of fluids in the body, separate from the blood, that deliver proteins, vitamins, and nutrients to different parts of the body. However, over time as the liver is subjected to unhealthy lymph, it can cause damage in the form of cholestasis. Lymphedema can progress later in older children into adulthood if their cholestasis is left untreated. This can cause swelling, usually in the lower extremities such as the legs, ankles, and feet. 

 

Aagenaes syndrome begins developing in newborns and young children. It normally starts with liver cholestasis, characterized by liver problems such as abdominal pain, abnormal stool, malabsorption of nutrients, and general liver dysfunction. If this persists without treatment, it can cause symptoms such as jaundice to progress. Jaundice is the yellowed discoloration of the skin due to a build up of bilirubin in the blood. Bilirubin is a waste product that is produced when the body breaks down red blood cells, and is normally filtered out of the blood and into the bile by the liver. When the liver is not functioning normally, excess bilirubin can build up in the blood causing toxic build-up and skin discoloration. Most children with Aagenaes syndrome receive proper vitamin treatment and their symptoms lessen to more episodic instances of liver problems. About half of all people diagnosed with Aagenaes syndrome will later develop lymphedema before ages 6-7 or right before puberty. Lymphoedema occurs when the body’s lymphatic system – or the fluid responsible for carrying important proteins throughout the body – is not working properly. This can cause swelling in the lower parts of the body, such as legs, ankles, and feet. Other symptoms experienced by individuals with Aagenaes syndrome can include:

Common:

  • Abdominal pain and upset stomach

  • Abnormal lymph function leading to lymphatic disease

  • Discolored stool (clay colored) due to a lack of bile

  • Fatigue

  • Rickets - softening or weakening of the bones due to a vitamin D deficiency

  • Hepatomegaly – increase in liver size

  • Nausea and vomiting – due to abdominal pain and upset stomach

  • Neonatal cholestatic liver disease

Less Common:

  • Multiple lipomas – benign tumors of fatty tissue

  • Discoloration of the skin due to jaundice

  • Splenomegaly – increase in spleen size

Least Common:

  • Bone pain – prickling, throbbing, or aching sensation localized to the bone

  • Cirrhosis – scarring of the liver tissue leading to loss of function

  • Gastrointestinal hemorrhage – bleeding from the internal organs involved in the digestive tract, leading to bloody stool

  • Portal hypertension – increased blood pressure in the portal vein

  • Reduced bone mineral – reduced bone density, which could cause complications such as osteoporosis

Early signs of lymphoedema can be difficult to detect, especially if there is not a prior family history of Aagenaes syndrome. Some cases of Aagenaes syndrome have been mistakenly misdiagnosed as biliary atresia, so an in-depth consultation with a pediatrician and hepatologist is necessary for a proper diagnosis.

 

The following are common tests conducted on newborns and small children in order to determine a diagnosis of Aagenaes syndrome:

  1. Testing for biomarkers – increased levels of bile acid, liver enzymes including aspartate transaminase (ALT), and alanine transaminase (AST) in the blood within one month of birth can indicate a diagnosis of Aagenaes syndrome

  2. Instrumental investigations – the use of imaging equipment such as abdominal ultrasonography and magnetic resonance cholangiopancreatography (MRCP) can reveal the source of dysfunction in the liver and lymphatic system

  3. Testing for lymphoedema – once the disease has progressed, lymphoedema can be diagnosed using lymphoscintigraphy (flowing a radioactive fluid through the lymph ducts to evaluate the process of emptying), CT or MRI scans, a duplex ultrasound

  4. Genetic testing for the mutation indicative of Aagenaes syndrome

Although there is no known cure for this disorder, treatments involving nutritional and multivitamin supplement use in early childhood have improved the prognosis for those living with Aagenaes syndrome. Other symptoms can be managed according to each individual case, and may include medications, clinical procedures, speech therapy, and other supportive care. If nutritional approaches do not affect symptoms during early childhood, a liver transplant may be necessary at a later age.

 

Because of improvements in understanding of this disease and other liver disorders, current therapeutic approaches to treating Aagenaes syndrome have improved length and quality of life. With treatment, many individuals with Aagenaes syndrome have shorter cholestatic episodes, lower risk for  rickets, and better overall growth. Some cases of Aagenaes syndrome can progress to lymphedema and other liver problems, which can reduce lifespan and ability to thrive.

 

Tips or Suggestions of Aagenaes Syndrome has not been added yet.
Logo

Aagenaes Syndrome community discussions will be posted here.

There are no new discussions. Start one now!!

Community Resources
Title Description Date Link

Clinical Trials


Cords registry

CoRDS, or the Coordination of Rare Diseases at Sanford, is based at Sanford Research in Sioux Falls, South Dakota. It provides researchers with a centralized, international patient registry for all rare diseases. This program allows patients and researchers to connect as easily as possible to help advance treatments and cures for rare diseases. The CoRDS team works with patient advocacy groups, individuals and researchers to help in the advancement of research in over 7,000 rare diseases. The registry is free for patients to enroll and researchers to access.

Enrolling is easy.

  1. Complete the screening form.
  2. Review the informed consent.
  3. Answer the permission and data sharing questions.

After these steps, the enrollment process is complete. All other questions are voluntary. However, these questions are important to patients and their families to create awareness as well as to researchers to study rare diseases. This is why we ask our participants to update their information annually or anytime changes to their information occur.

Researchers can contact CoRDS to determine if the registry contains participants with the rare disease they are researching. If the researcher determines there is a sufficient number of participants or data on the rare disease of interest within the registry, the researcher can apply for access. Upon approval from the CoRDS Scientific Advisory Board, CoRDS staff will reach out to participants on behalf of the researcher. It is then up to the participant to determine if they would like to join the study.

Visit sanfordresearch.org/CoRDS to enroll.

Community Leaders

 

Expert Questions

Ask a question

Community User List

Aagenes syndrome 

I am a patient with GAVE. IE...Watermelon stomach..causing iron deficiency anemia. Have had this for over 3 years.
I am health professional and likes to write on generic medicine.
Software Engineer
My name is David Isserman and I am one of the co-founders of RareShare. If you have any questions or feedback regarding RareShare, please feel free to contact me directly at david@rareshare.org.

Start a Community


Don't See Your Condition On Rareshare?

Start your own! With a worldwide network of 8,000 users, you won't be the only member of your community for long.

FAQ


Have questions about rareshare?

Visit our Frequently Asked Questions page to find the answers to some of the most commonly asked questions.

Discussion Forum

Logo

Aagenaes Syndrome community discussions will be posted here.

There are no new discussions. Start one now!!


Communities

Our Communities

Join Rareshare to meet other people that have been touched by rare diseases. Learn, engage, and grow with our communities.

FIND YOUR COMMUNITY
Physicians

Our Resources

Our rare disease resources include e-books and podcasts

VIEW OUR EBOOKS

LISTEN TO OUR PODCASTS

VIEW OUR GUIDES

Leaders

Our Community Leaders

Community leaders are active users that have been touched by the rare disease that they are a part of. Not only are they there to help facilitate conversations and provide new information that is relevant for the group, but they are there for you and to let you know you have a support system on Rareshare.